References for BioSig Fact Sheet

  1. Elrod, Jodie, “Incorporating Advanced Intracardiac Signal Information Into the Clinical Workflow, “EP Lab Digest”, December, 2021.
  2. Friedman, Paul A., “Novel Mapping Techniques for Cardiac Electrophysiology”, “Heart”, 2002; 87:575-582
  3. Al-Ahman, Amin MD, Knight, Bradley MD, et. al., “Evaluation of a novel cardiac signal processing system for electrophysiology procedures: The PURE EP 2.0 Study”, “ “Journal of Cardiac Electrophysiology”, September 5, 2021, pp.1-8
  4. Lakkireddy, DJ, MD, Univ. of Kansas Health System
  5. Cheung, J., MD, Yeo, I, MD, et. al., “Outcomes, Costs and 30-Day Readmissions After Catheter Ablation of Myocardial-Infarct-Associated Ventricular Tachycardia in the Real World”, “Circulation: Arrhythmia and Electrophysiology”, 2018;11e006754
  6. Tripathi, B. MD, Atti, B., MD et. al., Outcomes and Resource Utilization Associated with Readmission After Atrial Fibrillation Hospitalizations”, “Journal of the American Heart Association”, 2019;8:e013026
  7. Arora, S, MD, Lahewala, S., MD, et. al “Causes and Predictors of Readmission in Patients with Atrial Fibrillation Undergoing Catheter Ablation: A National Population Based Cohort Study, 2018, “Journal of the American Heart Association, (J Am Heart Assoc. 2018;7: e009294. DOI: 10.1161/JAHA 118.009294)
  8. Cardiovascular (https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/cardiovascular)
  9. Steinbeck, G. MD, Sinner, MF MD, “incidence of Complications Related to Catheter Ablation of Atrial Fibrillation and Flutter: A Nationwide In-Hospital Analysis of Administrative Data from Germany in 2014”, Eur Heart J 2018, 39:4020-4029.